The report "Empty Capsules Market by Type (Gelatin, Non-gelatin), Raw Material (Porcine, Bovine, HPMC), Functionality (Immediate, Sustained, Delayed), Application (Antibiotic, Dietary, CVD), Size (00 Capsule), End User (Pharma, Nutraceutical)-Global Forecast to 2030", is projected to reach USD 4.19 billion by 2030 from an estimated USD 3.19 billion in 2025, at CAGR of 5.6% from 2025 to 2030.
Browse 356 market data tables and 48 figures spread through 459 pages and in-depth TOC on “Empty Capsules market - Global Forecast to 2030.“
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/empty-capsules-market-218018190.html
Rising demand for personalized supplements and functional nutrition is fueling the need for capsules that meet diverse consumer preferences, especially in the nutraceuticals market. Additionally, the growing use of capsules in clinical trials, demand for modified-release capsules, and the shift toward clean-label, vegan capsules are also driving growth in the market for empty capsules used in pharmaceuticals. Furthermore, sustainability trends are motivating manufacturers to invest in biodegradable and eco-friendly solutions, opening new opportunities in emerging markets.
Immediate-release capsules segment is expected to dominate the empty capsules market by functionality.
By functionality, the empty capsules market is categorized into immediate-release capsules, sustained-release capsules, delayed-release capsules, and modified-release capsules. The immediate-release capsules segment is the largest in the empty capsules market. These capsules are typically used for medications and supplements where a rapid onset of action is necessary. They are the most commonly used type of capsule, favored for their simple formulation and relatively low production cost. Immediate-release capsules are employed in treating acute conditions such as pain relief, antibiotics, and other fast-acting drugs.
Dietary supplements application segment is expected to grow with the highest CAGR during the forecast period.
The empty capsules market is categorized based on therapeutic applications, including antibiotic and antibacterial drugs, dietary supplements, antacid & antiflatulent preparations, anti-inflammatory drugs, cardiovascular therapy drugs, cough & cold treatments, and other therapeutic uses. Among these, the dietary supplements segment is the fastest-growing, driven by the increasing demand for natural supplements, probiotics, and vegan alternatives. This growth is fueled by a shift toward preventive healthcare and a rising interest in personalized nutrition. Additionally, the development of plant-based and clean-label products contributes to this segment's expansion as consumers become more health-conscious and choose supplements that match their dietary preferences. The global aging population and the rising prevalence of lifestyle diseases also boost the reliance on dietary supplements as part of proactive health management.
The North America region accounted for the largest share of the empty capsules market in 2024.
The empty capsules market is segmented into North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. In 2024, North America held the largest share of the global empty capsules market, driven by its well-established pharmaceutical and nutraceutical industries, high healthcare expenditure, and increasing demand for dietary supplements. Furthermore, the rising preference for vegetarian and clean-label capsules among health-conscious consumers has further fueled demand. Regulatory support and a high volume of clinical trials also help maintain the region’s leading position in the market.
Key players in the empty capsules market include Lonza (Switzerland), ACG (India), Qualicaps (US), Suheung (South Korea), and Shanxi Guangsheng Capsule Limited (China), among others. Some of the SMEs/start-ups operating in this market includes SaviourCaps (India), Shanxi JC Biological Technology Co. (China), Shaoxing Kangke Capsule Co., Ltd. (China), ZHEJIANG HUILI CAPSULES CO., LTD. (China), and Lefancaps (Canada), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/